Showing results (311-320 of 413) with videos related to

Sort By:
Pageof 42
The Journal of Pathology|August 9, 2023
DNA methylation-associated allelic inactivation regulates Keratin 19 gene expression during pancreatic development and carcinogenesisJana Krüger, Anja Fischer, Markus Breunig, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 5, 2016
Treatment sequence of synchronously (liver) metastasized colon cancerThomas Gruenberger, Geerard Beets, Jean-Luc Van Laethem, et al.
European Journal of Clinical Pharmacology|December 14, 2019
Personalising drug safety-results from the multi-centre prospective observational study on Adverse Drug Reactions in Emergency Departments (ADRED)Katja S Just, Harald Dormann, Miriam Böhme, et al.
Journal of Cancer Research and Clinical Oncology|December 30, 2017
CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomachHarald Schmalenberg, Salah-Eddin Al-Batran, Claudia Pauligk, et al.
Stem Cells International|July 9, 2019
MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells In Vitro and In VivoKarolin Walter, Kanishka Tiwary, Marija Trajkovic-Arsic, et al.
Gastroenterology|May 25, 2020
Protein Kinase D1, Reduced in Human Pancreatic Tumors, Increases Secretion of Small Extracellular Vesicles From Cancer Cells That Promote Metastasis to Lung in MiceMilena Armacki, Sandra Polaschek, Mareike Waldenmaier, et al.
Plos One|June 4, 2021
Digitalization of adverse event management in oncology to improve treatment outcome-A prospective study protocolAngelika M R Kestler, Silke D Kühlwein, Johann M Kraus, et al.
Frontiers in Oncology|April 5, 2021
Efficacy of Stereotactic Body Radiotherapy in Patients With Hepatocellular Carcinoma Not Suitable for Transarterial Chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)Thomas B Brunner, Dominik Bettinger, Michael Schultheiss, et al.
Cancers|September 10, 2021
Targeting DNA Damage Repair Mechanisms in Pancreas CancerLukas Perkhofer, Talia Golan, Pieter-Jan Cuyle, et al.
Scientific Reports|April 16, 2026
A CXCR4 targeting peptide delivered by silica nanoparticles eliminates migrating cancer stem cells in pancreatic ductal adenocarcinomaKanishka Tiwary, Anton Lahusen, Syeda Inaas, et al.
Pageof 42